FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4816411000001103: Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1888301000001115 Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1888321000001110 Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Is a Co-cyprindiol 2000microgram/35microgram tablets 63 tablet true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Is pack of Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has active ingredient Cyproterone acetate false Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has AMP Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Cyproterone acetate true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Discontinued indicator Re-marketed true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start